A Phase 1, Randomized, Dose Escalation, Single Center, Safety Study of Single and Multi-Dose, Topically Applied OLT1177 Gel in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Dapansutrile (Primary)
- Indications Inflammation; Musculoskeletal pain
- Focus Adverse reactions
- Sponsors Olatec Therapeutics
- 28 Dec 2017 Last checked against ClinicalTrials.gov record.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2012 New trial record